LFVN · NASDAQ
LifeVantage Corporation
$5.90 -0.01 (-0.17%)
Company overview
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements, LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3, LifeVantage ProBio, a dietary supplement to support digestive system health, a line of weight management products under the PhysIQ brand, Petandim for Dogs, a supplement to combat oxidative stress in dogs, and Axio, a line of energy drink mixes.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Exchange
- NASDAQ
- Market cap
- $74.3M
- Employees
- 222
- Headquarters
- Lehi, UT
- Website
- lifevantage.com
- CEO
- Steven R. Fife
- Listed
- April 7, 1994
- P/E
- 12.78
- Dividend yield
- 3.05%
Company financials
- Revenue
- $195M
- Gross profit
- $153M
- Operating income
- $6.6M
- EBITDA
- $9.4M
- Net income
- $5.8M
- EPS
- $0.46
- Total assets
- $62.1M
- Total debt
- $10.2M
- Gross margin
- 78.14%
- Net margin
- 2.94%
- Earnings yield
- 7.83%
Showing FY 2026
LFVN
1D
NASDAQ
O5.89H5.95L5.78C5.89-0.04 (-0.67%)Vol11.25K